Eligibility Module

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module

Ignite Creation Date: 2025-12-25 @ 2:51 AM
Ignite Modification Date: 2025-12-25 @ 2:51 AM
NCT ID: NCT05552833
Eligibility Criteria: Inclusion criteria -patients * Men and women * 45-80 years * COPD (GOLD stage I to III) * Forced expiratory volume in 1 sec (FEV1)/forced vital capacity ratio (FVC) \< 0.8, FEV1 \< 90% of predicted value * Modified Medical Research Council score (mMRC 0 - 3) * Resting arterial oxygenation \> 90% * Do not fulfil the physical activity recommendations by the Danish Health Authority Inclusion criteria - controls * Men and women * 45-80 years * Normal FEV1, FVC, FEV1/FVC, and single-breath diffusion capacity * Same sex, age (± 3 years) and BMI (± 10%) * Do not fulfil the physical activity recommendations by the Danish Health Authority (19) * BMI 18-35 Exclusion criteria - patients * Symptoms of ischaemic heart disease * Known heart failure * Previous severe or current COVID-19 * Unable to complete or understand HIIT training * Claudication * Symptoms of disease within 2 weeks prior to the study * Participation in pulmonary rehabilitation within 6 months * Known malignant disease * Pregnancy * Unstable cardiac arrhythmic disease * Renal or liver dysfunction Exclusion criteria - controls * COPD * Asthma * Known ischaemic heart disease * Known heart failure * Previous severe or current COVID-19 * Unable to complete or understand HIIT training * Symptoms of disease within 2 weeks prior to the study * Known malignant disease * Claudication * Pregnancy * Unstable cardiac arrhythmic disease * Renal or liver dysfunction
Healthy Volunteers: True
Sex: ALL
Minimum Age: 45 Years
Maximum Age: 80 Years
Study: NCT05552833
Study Brief:
Protocol Section: NCT05552833